J&J, Basilea To Base Ceftobiprole Filing For Hospital-Acquired Pneumonia On Phase III Results

Despite positive results in patients with hospital-acquired pneumonia, the Phase III study failed to demonstrate non-inferiority in a high-risk subgroup.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet